Statistics

Total Visits

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group41

Select a period of time:

Number of views in the range

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group27

Views

Views
November 20241
December 20240
January 20257
February 20251
March 202515
April 20252
May 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States5
United Kingdom3
Chile2
Brazil1
Spain1
 

Top cities views

Views
Wilmington2
Santiago Metropolitan2
Council Bluffs1
São Paulo1